Filtered By:
Source: Respiratory Care
Vaccination: Influenza Vaccine
This page shows you your search results in order of date.
Order by Relevance | Date
Total 70 results found since Jan 2013.
Healthcare personnel in 2016-2019 prospective cohort infrequently got vaccinated, worked while ill, and frequently used antibiotics rather than antivirals against viral influenza illnesses
Influenza Other Respir Viruses. 2023 Sep 7;17(9):e13189. doi: 10.1111/irv.13189. eCollection 2023 Sep.ABSTRACTBACKGROUND: Uncertainty about risk of illness and the value of influenza vaccines negatively affects vaccine uptake among persons targeted for influenza vaccination.METHODS: During 2016-2019, we followed a cohort of healthcare personnel (HCP) targeted for free-of-charge influenza vaccination in five Lima hospitals to quantify risk of influenza, workplace presenteeism (coming to work despite illness), and absenteeism (taking time off from work because of illness). The HCP who developed acute respiratory illnesses (A...
Source: Respiratory Care - September 11, 2023 Category: Respiratory Medicine Authors: Eduardo Azziz-Baumgartner Joan Neyra Tat S Yau Giselle Soto Daniel Owusu Chao Zhang Candice Romero Young M Yoo Miriam Gonzales Yeny Tinoco Mar ía Silva Eduar Bravo Nancy Rojas Serrano Eduardo Matos Victor Chavez-Perez Juan Carlos Castro Maria Esther Cast Source Type: research
Age-specific severity of severe acute respiratory syndrome coronavirus 2 in February 2020 to June 2021 in the Netherlands
CONCLUSION: Whereas the increase in severity of Severe Acute Respiratory Syndrome Coronavirus 2 with age remained stable, the risk of death upon infection decreased over time. A significant drop in risk of death among elderly coincided with the introduction of COVID-19 vaccination.PMID:37621921 | PMC:PMC10444602 | DOI:10.1111/irv.13174
Source: Respiratory Care - August 25, 2023 Category: Respiratory Medicine Authors: Pieter T de Boer Jan van de Kassteele Eric R A Vos Liselotte van Asten Dave A Dongelmans Arianne B van Gageldonk-Lafeber Gerco den Hartog Agnetha Hofhuis Fiona van der Klis Dylan W de Lange Lenny Stoeldraijer RIVM COVID ‐19 epidemiology and surveillance Source Type: research
Estimating SARS-CoV-2 infections and associated changes in COVID-19 severity and fatality
CONCLUSIONS: Since 2021, changes in the dominant SARS-CoV-2 variant, vaccination rollout, and the shift of infection to younger ages have reduced SARS-CoV-2 infection ascertainment. The same factors, combined with the improvement of patient management and care, contributed to a massive reduction in the severity and fatality of COVID-19.PMID:37599801 | PMC:PMC10432583 | DOI:10.1111/irv.13181
Source: Respiratory Care - August 21, 2023 Category: Respiratory Medicine Authors: Valentina Marziano Giorgio Guzzetta Francesco Menegale Chiara Sacco Daniele Petrone Alberto Mateo Urdiales Martina Del Manso Antonino Bella Massimo Fabiani Maria Fenicia Vescio Flavia Riccardo Piero Poletti Mattia Manica Agnese Zardini Valeria d'Andrea Fi Source Type: research
Understanding the Global Burden of Influenza in Adults Aged 18-64 years: A Systematic Literature Review from 2012 to 2022
CONCLUSIONS: High levels of hospitalization and outpatient visits demonstrated a clinical influenza-associated burden on patients and healthcare systems, which is exacerbated by comorbidities. Considering the size and breadth of the general population aged 18-64 years, the limited humanistic and economic findings of this SLR likely reflect an underreported burden. Greater investigation into indirect costs and prolonged absenteeism associated with influenza infection is required to fully understand the economic burden in this population.PMID:37470942 | DOI:10.1007/s12325-023-02610-1
Source: Respiratory Care - July 20, 2023 Category: Respiratory Medicine Authors: Farzaneh Maleki Verna Welch Santiago M C Lopez Alejandro Cane Jakob Langer Ashley Enstone Kristen Markus Olivia Wright Nicole Hewitt Isabelle Whittle Source Type: research
Barriers to and facilitators of populational adherence to prevention and control measures of COVID-19 and other respiratory infectious diseases: a qualitative evidence synthesis
CONCLUSIONS: This review suggests that financial and social support, assertive communication, trust in political authorities and greater regulation of social media enhance adherence to prevention and control measures for COVID-19 and infectious respiratory diseases. Designing and implementing effective educational public health interventions targeting the findings of barriers and facilitators highlighted in this review are key to reducing the impact of infectious respiratory diseases at the population level.PMID:37343960 | DOI:10.1183/16000617.0238-2022
Source: Respiratory Care - June 21, 2023 Category: Respiratory Medicine Authors: T ácito Zaildo Thayla Amorim Santino Gabriela Chaves Baldomero Antonio Kato da Silva Jo ão Carlos Alchieri Cecilia M Patino Sarah Leite Kleber Giovanni Luz Ricardo Oliveira Guerra Tito Hugo Soares da Penha Gabriel Rodrigues da Silva Ada Cristina J ácom Source Type: research
The impact of COVID-19 on residents of long-term care facilities with learning disabilities and/or autism
CONCLUSIONS: Care home residents with learning disabilities and/or autism have a greater risk of death from COVID-19. Optimising guidance to meet their needs is of great importance.PMID:37123814 | PMC:PMC10133727 | DOI:10.1111/irv.13139
Source: Respiratory Care - May 1, 2023 Category: Respiratory Medicine Authors: Elise Tessier Harriet Webster Nurin Abdul Aziz Joe Flannagan Asad Zaidi Andre Charlett Gavin Dabrera Theresa Lamagni Source Type: research
COVID-19 (Omicron strain) hospital admissions from a virtual ward - who required further care?
CONCLUSIONS: Few patients required admission from the virtual ward in the setting of the Omicron variant (BA.1, BA.2) as a direct result of COVID-19 disease and virtual ward care. Shortness of breath and chest pain were the most common symptoms driving further clinical care.PMID:36991540 | PMC:PMC10040950 | DOI:10.1111/irv.13108
Source: Respiratory Care - March 30, 2023 Category: Respiratory Medicine Authors: Ian Mackay Megan France Duncan McAuley Sean Wing Mary Wheeldon Susan Britton Catherine Todd Alexandra Pitiris Leah Barrett-Beck Elizabeth Rushbrook Cameron Bennett Kate McCarthy Source Type: research
Effectiveness of two and three mRNA COVID-19 vaccine doses against Omicron- and Delta-Related outpatient illness among adults, October 2021-February 2022
CONCLUSIONS: In this adult population, three mRNA COVID-19 vaccine doses provided substantial protection against symptomatic illness in outpatient settings when the Omicron variant became the predominant cause of COVID-19 in the United States. These findings support the recommendation for a third mRNA COVID-19 vaccine dose.PMID:36825251 | PMC:PMC9353375 | DOI:10.1111/irv.13029
Source: Respiratory Care - February 24, 2023 Category: Respiratory Medicine Authors: Sara S Kim Jessie R Chung H Keipp Talbot Carlos G Grijalva Karen J Wernli Erika Kiniry Emily T Martin Arnold S Monto Edward A Belongia Huong Q McLean Manjusha Gaglani Mufaddal Mamawala Mary Patricia Nowalk Krissy Moehling Geffel Sara Y Tartof Ana Florea J Source Type: research
An intercountry comparison of the impact of the paediatric live attenuated influenza vaccine (LAIV) programme across the UK and the Republic of Ireland (ROI), 2010 to 2017
CONCLUSIONS: Findings of this study suggest that LAIV vaccination of primary school age children is associated with population-level benefits, particularly in reducing infection incidence in primary care.PMID:36824392 | PMC:PMC9942272 | DOI:10.1111/irv.13099
Source: Respiratory Care - February 24, 2023 Category: Respiratory Medicine Authors: Mary A Sinnathamby Fiona Warburton Arlene J Reynolds Simon Cottrell Mark O'Doherty Lisa Domegan Joan O'Donnell Jillian Johnston Ivelina Yonova Suzanne Elgohari Nicola L Boddington Nick Andrews Joanna Ellis Simon de Lusignan Jim McMenamin Richard G Pebody Source Type: research
National seroepidemiological study of COVID-19 after the initial rollout of vaccines: Before and at the peak of the Omicron-dominant period in Japan
CONCLUSIONS: Before Omicron, the cumulative burden was >10 times lower in Japan (2.2%) compared with the US (33%), the UK (25%), or global estimates (45%), but most developed antibodies owing to vaccination.PMID:36824391 | PMC:PMC9890143 | DOI:10.1111/irv.13094
Source: Respiratory Care - February 24, 2023 Category: Respiratory Medicine Authors: Takeshi Arashiro Satoru Arai Ryo Kinoshita Kanako Otani Sho Miyamoto Daisuke Yoneoka Taro Kamigaki Hiromizu Takahashi Hiromi Hibino Mai Okuyama Ai Hayashi Fuka Kikuchi Saeko Morino Sayaka Takanashi Takaji Wakita Keiko Tanaka-Taya Tadaki Suzuki Motoi Suzuk Source Type: research
Effectiveness of two and three mRNA COVID-19 vaccine doses against Omicron- and Delta-Related outpatient illness among adults, October 2021-February 2022
CONCLUSIONS: In this adult population, three mRNA COVID-19 vaccine doses provided substantial protection against symptomatic illness in outpatient settings when the Omicron variant became the predominant cause of COVID-19 in the United States. These findings support the recommendation for a third mRNA COVID-19 vaccine dose.PMID:36825251 | PMC:PMC9353375 | DOI:10.1111/irv.13029
Source: Respiratory Care - February 24, 2023 Category: Respiratory Medicine Authors: Sara S Kim Jessie R Chung H Keipp Talbot Carlos G Grijalva Karen J Wernli Erika Kiniry Emily T Martin Arnold S Monto Edward A Belongia Huong Q McLean Manjusha Gaglani Mufaddal Mamawala Mary Patricia Nowalk Krissy Moehling Geffel Sara Y Tartof Ana Florea J Source Type: research
